Drug interactions with smoking.

@article{Kroon2007DrugIW,
  title={Drug interactions with smoking.},
  author={Lisa A. Kroon},
  journal={American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists},
  year={2007},
  volume={64 18},
  pages={
          1917-21
        }
}
PURPOSE The mechanisms for drug interactions with smoking and clinically significant pharmacokinetic and pharmacodynamic drug interactions with smoking are reviewed. SUMMARY Polycyclic aromatic hydrocarbons (PAHs) are some of the major lung carcinogens found in tobacco smoke. PAHs are potent inducers of the hepatic cytochrome P-450 (CYP) isoenzymes 1A1, 1A2, and, possibly, 2E1. After a person quits smoking, an important consideration is how quickly the induction of CYP1A2 dissipates. The… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 115 CITATIONS, ESTIMATED 43% COVERAGE

Impact of substance use on the physical health of patients with bipolar disorder.

  • Acta psychiatrica Scandinavica
  • 2009
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

In vitro analysis of factors influencing CYP1A2 expression as potential determinants of interindividual variation

  • Pharmacology research & perspectives
  • 2017
VIEW 5 EXCERPTS
CITES RESULTS & BACKGROUND
HIGHLY INFLUENCED

Review: Treating patients with respiratory disease who smoke

  • Therapeutic advances in respiratory disease
  • 2008
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2004
2019

CITATION STATISTICS

  • 10 Highly Influenced Citations

References

Publications referenced by this paper.
SHOWING 1-10 OF 33 REFERENCES

A pilot study of plasma caffeine concentrations in a US sample of smoker and nonsmoker volunteers

J DeLeon, FJ Diaz, T Rogers
  • Prog Neuropsychopharmacol Biol Psychiatry
  • 2003